imo csl made a big mistake buy most iof the u.s .a blood supply
seeming how blood products have a short shelf life and gdp can etxtract much higher yields you dont need a massive blood supply ( THIS IS THE MAIN REASON I WONT BUY CSL ) AS FOR GDP fractionation is aonly a small % of the total potention activities they could perform
it its also my opinion that gdp mis grossly under valued atm this is bargain basement prices atm investment stock or what its been a 5 yr wait but should be more than worth it imo $50 is a start once they are up and running
with a small j/v finding a test for madcow potential mkt $ 2.5 bill imagine what else they could do just in the biologic tests dept as a research tool it could be a standard
